166 related articles for article (PubMed ID: 22864669)
1. International veterinary bioequivalence guideline similarities and differences between Australia, Canada, Europe, Japan, New Zealand and the United States.
Lainesse C
AAPS J; 2012 Dec; 14(4):792-8. PubMed ID: 22864669
[TBL] [Abstract][Full Text] [Related]
2. International guidelines for bioequivalence of systemically available orally administered generic drug products: a survey of similarities and differences.
Davit B; Braddy AC; Conner DP; Yu LX
AAPS J; 2013 Oct; 15(4):974-90. PubMed ID: 23821352
[TBL] [Abstract][Full Text] [Related]
3. Regulatory Considerations of Bioequivalence Studies for Oral Solid Dosage Forms in Japan.
Kuribayashi R; Takishita T; Mikami K
J Pharm Sci; 2016 Aug; 105(8):2270-7. PubMed ID: 27372551
[TBL] [Abstract][Full Text] [Related]
4. Considerations for extrapolating in vivo bioequivalence data across species and routes.
Modric S; Bermingham E; Heit M; Lainesse C; Thompson C
J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():45-52. PubMed ID: 22413791
[TBL] [Abstract][Full Text] [Related]
5. International Guidelines for Bioequivalence of Locally Acting Orally Inhaled Drug Products: Similarities and Differences.
Lu D; Lee SL; Lionberger RA; Choi S; Adams W; Caramenico HN; Chowdhury BA; Conner DP; Katial R; Limb S; Peters JR; Yu L; Seymour S; Li BV
AAPS J; 2015 May; 17(3):546-57. PubMed ID: 25758352
[TBL] [Abstract][Full Text] [Related]
6. International harmonization of bioequivalence studies and issues shared in common.
Nakai K; Fujita M; Ogata H
Yakugaku Zasshi; 2000 Nov; 120(11):1193-200. PubMed ID: 11190204
[TBL] [Abstract][Full Text] [Related]
7. Challenges associated with the evaluation of veterinary product bioequivalence: an AAVPT perspective.
Martinez M; Langston C; Martin T; Conner D
J Vet Pharmacol Ther; 2002 Jun; 25(3):201-20. PubMed ID: 12081616
[TBL] [Abstract][Full Text] [Related]
8. Current challenges facing the determination of product bioequivalence in veterinary medicine.
Martinez MN; Hunter RP
J Vet Pharmacol Ther; 2010 Oct; 33(5):418-33. PubMed ID: 20840385
[TBL] [Abstract][Full Text] [Related]
9. The Global Bioequivalence Harmonization Initiative: Summary report for EUFEPS international conference.
Chen ML; Blume H; Beuerle G; Davit B; Mehta M; Potthast H; Schug B; Tsang YC; Wedemeyer RS; Weitschies W; Welink J
Eur J Pharm Sci; 2018 Jan; 111():153-157. PubMed ID: 28964950
[TBL] [Abstract][Full Text] [Related]
10. Survey of international regulatory bioequivalence recommendations for approval of generic topical dermatological drug products.
Braddy AC; Davit BM; Stier EM; Conner DP
AAPS J; 2015 Jan; 17(1):121-33. PubMed ID: 25344440
[TBL] [Abstract][Full Text] [Related]
11. Establishing bioequivalence of veterinary premixes (Type A medicated articles).
Hunter RP; Lees P; Concordet D; Toutain PL
J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():53-63. PubMed ID: 22413792
[TBL] [Abstract][Full Text] [Related]
12. Harmonization of regulatory approaches for evaluating therapeutic equivalence and interchangeability of multisource drug products: workshop summary report.
Chen ML; Shah VP; Crommelin DJ; Shargel L; Bashaw D; Bhatti M; Blume H; Dressman J; Ducharme M; Fackler P; Hyslop T; Lutter L; Morais J; Ormsby E; Thomas S; Tsang YC; Velagapudi R; Yu LX
Eur J Pharm Sci; 2011 Nov; 44(4):506-13. PubMed ID: 21946259
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial resistance and the guidelines of the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH).
Marion H
Rev Sci Tech; 2012 Apr; 31(1):299-306. PubMed ID: 22849284
[TBL] [Abstract][Full Text] [Related]
14. Challenges obtaining a biowaiver for topical veterinary dosage forms.
Baynes R; Riviere J; Franz T; Monteiro-Riviere N; Lehman P; Peyrou M; Toutain PL
J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():103-14. PubMed ID: 22413798
[TBL] [Abstract][Full Text] [Related]
15. Modernization and Strengthening of Bioequivalence Guidelines in Japan.
Kuribayashi R; Yamaguchi T; Takagi K
Clin Pharmacokinet; 2021 Feb; 60(2):145-151. PubMed ID: 33247363
[TBL] [Abstract][Full Text] [Related]
16. Comparison of bioequivalence study regulatory requirements for human and veterinary drugs.
Grabowski T; Marczak M; Jaroszewski JJ; Whitmire M
Regul Toxicol Pharmacol; 2012 Nov; 64(2):233-42. PubMed ID: 22917973
[TBL] [Abstract][Full Text] [Related]
17. Variability and impact on design of bioequivalence studies.
Van Peer A
Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):146-53. PubMed ID: 20041877
[TBL] [Abstract][Full Text] [Related]
18. Veterinary drug bioequivalence determination.
Toutain PL; Koritz GD
J Vet Pharmacol Ther; 1997 Apr; 20(2):79-90. PubMed ID: 9131533
[TBL] [Abstract][Full Text] [Related]
19. Demonstrating comparative in vitro bioequivalence for animal drug products through chemistry and manufacturing controls and physicochemical characterization: a proposal.
Martinez MN; Fahmy R
AAPS J; 2015 Mar; 17(2):307-12. PubMed ID: 25609223
[TBL] [Abstract][Full Text] [Related]
20. Current regulatory approaches of bioequivalence testing.
Karalis V; Macheras P
Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):929-42. PubMed ID: 22681436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
